These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 18166186

  • 1. Inhibition of cyclooxygenase-2 (COX-2) by meloxicam decreases the incidence of ovarian hyperstimulation syndrome in a rat model.
    Quintana R, Kopcow L, Marconi G, Young E, Yovanovich C, Paz DA.
    Fertil Steril; 2008 Oct; 90(4 Suppl):1511-6. PubMed ID: 18166186
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The effects of resveratrol on ovarian hyperstimulation syndrome in a rat model.
    Ozgur S, Oktem M, Altinkaya SO, Oktem EO, Cenksoy C, Erdem O, Elbeg S, Helvaci A, Erdem A, Erdem M.
    Taiwan J Obstet Gynecol; 2018 Jun; 57(3):383-388. PubMed ID: 29880170
    [Abstract] [Full Text] [Related]

  • 4. In vivo intrabursal administration of bioactive lipid sphingosine-1-phosphate enhances vascular integrity in a rat model of ovarian hyperstimulation syndrome.
    Di Pietro M, Pascuali N, Scotti L, Irusta G, Bas D, May M, Tesone M, Abramovich D, Parborell F.
    Mol Hum Reprod; 2017 Jun 01; 23(6):417-427. PubMed ID: 28379469
    [Abstract] [Full Text] [Related]

  • 5. Ovarian hyperstimulation syndrome inhibition by targeting VEGF, COX-2 and calcium pathways: a preclinical randomized study.
    Kitsou C, Kosmas I, Lazaros L, Hatzi E, Euaggelou A, Mynbaev O, Tournaye H, Prapas N, Prapas I, Zikopoulos K, Galani V, Georgiou I.
    Gynecol Endocrinol; 2014 Aug 01; 30(8):587-92. PubMed ID: 24819316
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Oxytocin and cabergoline alleviate ovarian hyperstimulation syndrome (OHSS) by suppressing vascular endothelial growth factor (VEGF) in an experimental model.
    Hortu I, Karadadas E, Ozceltik G, Tavmergen E, Tavmergen Goker EN, Yigitturk G, Erbas O.
    Arch Gynecol Obstet; 2021 Apr 01; 303(4):1099-1108. PubMed ID: 33140116
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Administration of a gonadotropin-releasing hormone agonist affects corpus luteum vascular stability and development and induces luteal apoptosis in a rat model of ovarian hyperstimulation syndrome.
    Scotti L, Irusta G, Abramovich D, Tesone M, Parborell F.
    Mol Cell Endocrinol; 2011 Mar 30; 335(2):116-25. PubMed ID: 21238536
    [Abstract] [Full Text] [Related]

  • 11. Comparison of montelukast and cabergoline for prevention of ovarian hyperstimulation syndrome: in an experimental rat model.
    Akman L, Sahin G, Erbas O, Aktug H, Akdogan A, Goker EN, Taskiran D, Tavmergen E.
    Gynecol Endocrinol; 2015 May 30; 31(5):369-73. PubMed ID: 25599748
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effect of varying doses of tamoxifen on ovarian histopathology, serum VEGF, and endothelin 1 levels in ovarian hyperstimulation syndrome: an experimental study.
    Pala Ş, Atilgan R, Ozkan ZS, Kavak SB, Ilhan N, Akpolat N, Sapmaz E.
    Drug Des Devel Ther; 2015 May 30; 9():1761-6. PubMed ID: 25848212
    [Abstract] [Full Text] [Related]

  • 18. Comparison between resveratrol and cabergoline in preventing ovarian hyperstimulation syndrome in a rat model.
    Kasap E, Turan GA, Eskicioğlu F, Cengiz H, Gur EB, Sivrikoz ON, Genc M, Yılmaz O.
    Gynecol Endocrinol; 2016 Aug 30; 32(8):634-640. PubMed ID: 26939766
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.